DEANNA MICHELLE LALAMA: Open Payments
NPI 1528007259 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,140 in 157 payments from 22 companies in 2025. Trend: 2023 $2,854 · 2024 $4,955 · 2025 $3,140
Food & beverage: $3,041Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 38 | $608 |
| ABBVIE INC. | 25 | $415 |
| Janssen Biotech, Inc. | 16 | $362 |
| UCB, Inc. | 21 | $360 |
| Novartis Pharmaceuticals Corporation | 8 | $250 |
| GENZYME CORPORATION | 5 | $210 |
| PFIZER INC. | 9 | $172 |
| Alexion Pharmaceuticals, Inc. | 4 | $105 |
| Mallinckrodt Hospital Products Inc. | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
Products named: Bimzelx, TREMFYA, RINVOQ, COSENTYX, KEVZARA, ENBREL, XELJANZ, OTEZLA.
Industry payments across NC — which companies pay providers there.
